Linda Jean Romero, MD | |
3200 Carlisle Blvd. Ne, Suite 209, Albuquerque, NM 87110 | |
(505) 889-4587 | |
(505) 889-4519 |
Full Name | Linda Jean Romero |
---|---|
Gender | Female |
Speciality | Family Medicine |
Location | 3200 Carlisle Blvd. Ne, Albuquerque, New Mexico |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366459315 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 84-249 (New Mexico) | Primary |
Entity Name | Unm Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
Patients with locally advanced cervical cancer benefit significantly from an innovative radiotherapy technique co-developed by MedUni Vienna under the direction of Richard Pötter and Christian Kirisits. The technique provides better tumor control and produces fewer side-effects.
Breast cancer patients in the U.S. will have a new surgical option that eliminates exposure to radioactive materials and offers a less invasive, more flexible alternative for cancer detection. Receiving FDA approval in April and a distribution deal this month, the new device will be used to locate early stage tumors that cannot yet be felt.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of aldoxorubicin for the treatment of Kaposi's Sarcoma (KS) in HIV-infected patients.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Researchers from Greece say that the use of steroid inhalers in elementary school children with asthma may improve school performance over other forms of therapy.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Linda Jean Romero, MD 933 Bradbury Dr Se, Suite 2222, Albuquerque, NM 87106-4374 Ph: (505) 272-3120 | Linda Jean Romero, MD 3200 Carlisle Blvd. Ne, Suite 209, Albuquerque, NM 87110 Ph: (505) 889-4587 |
News Archive
Patients with locally advanced cervical cancer benefit significantly from an innovative radiotherapy technique co-developed by MedUni Vienna under the direction of Richard Pötter and Christian Kirisits. The technique provides better tumor control and produces fewer side-effects.
Breast cancer patients in the U.S. will have a new surgical option that eliminates exposure to radioactive materials and offers a less invasive, more flexible alternative for cancer detection. Receiving FDA approval in April and a distribution deal this month, the new device will be used to locate early stage tumors that cannot yet be felt.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced positive interim results from its ongoing Phase 2 clinical trial evaluating the safety and efficacy of aldoxorubicin for the treatment of Kaposi's Sarcoma (KS) in HIV-infected patients.
A sub-study of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial, designed to investigate the effect of insulin glargine and omega-3 fatty acids on atherosclerosis progression, has found that, compared to standard care, only insulin glargine (a long-acting insulin) had a "modest" statistically non-significant reducing effect on the primary outcome of rate of change in maximum carotid intima media thickness (CIMT) at 12 carotid sites.
Researchers from Greece say that the use of steroid inhalers in elementary school children with asthma may improve school performance over other forms of therapy.
› Verified 6 days ago
Anne Jones, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8300 Constitution Ave Ne, Albuquerque, NM 87110 Phone: 505-272-2700 | |
Dr. Matias James Vega, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1217 1st St Nw, Albuquerque Health Care For The Homeless, Albuquerque, NM 87102 Phone: 505-242-4644 Fax: 505-242-3531 | |
Bill Daugherty, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 5901 Harper Dr Ne, Pmg Urgent Care, Albuquerque, NM 87109 Phone: 505-823-8233 Fax: 505-823-8059 | |
Mr. John A Bond, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4420 Irving Blvd Nw, Albuquerque, NM 87114 Phone: 505-727-6300 Fax: 505-727-9588 | |
Margaret Peggy Spencer, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1501 San Pedro Dr Se, Albuquerque, NM 87108 Phone: 505-265-1711 Fax: 505-256-6414 | |
Daniel L. Stulberg, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Msc 09 5040, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-2165 | |
Carrie A Irvin, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1524 Eubank Blvd Ne Ste 6, Albuquerque, NM 87112 Phone: 505-503-8806 Fax: 888-503-8511 |